NSE:WOCKPHARMA - Wockhardt Stock Price & Analysis

About Wockhardt (NSE:WOCKPHARMA)

(NSE:WOCKPHARMA) Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients, formulations, bio-similars, and vaccines in India, the United States, Europe, and internationally. It provides pharmaceutical products in the therapeutic areas of anti-infective, cardiology, dermatology, diabetology, neurology, pain management, respiratory, and other areas. The company offers generic products that comprise injectables, including cephalosporins and non-cephalosporins; molecules; and value-added generics. Its biopharmaceutical products include Glaritus, an insulin analog; Wosulin, an r-DNA insulin; Wepox, a recombinant erythropoietin that is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. The company also provides contract manufacturing services for sterile injectables, lyophilisation, and other dosage forms; and research services. It develops various molecules primarily in the area of anti-infectives, which include WCK 771 and WCK 2349 that is in Phase II human clinical trials for the treatment of staphylococcal infections; and WCK 5222, WCK 4282, WCK 4873, and WCK 6777 lead molecules, which are under pre-clinical trials. The company was incorporated in 1999 and is headquartered in Mumbai, India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited.

WOCKPHARMA Stock Price

Statistics Highlights (NSE:WOCKPHARMA)

Shares Outstanding	144.06M	Beta	1.50
Public Float	53.90M	P/E Ratio	-
% Short of Float	-	Dividend (Yield)	-
Held by Insiders	69.48%	Ex-Dividend Date	Nov 17, 2016
Held by Institutions	1.96%	IPO Date	-

Explore More on "Statistics" Section

WOCKPHARMA Financial Summary

|

	Mar 22	Mar 21	Mar 20
Revenue	INR32.30B	INR26.99B	INR28.33B
EBITDA	INR1.35B	INR9.04B	INR2.22B
Net Income	INR-2.44B	INR6.86B	INR-692.20M
Total Assets	INR82.43B	INR77.73B	INR81.79B
Total Cash	INR4.06B	INR2.32B	INR2.19B
Total Debt	INR	INR26.73B	INR35.82B

	Mar 22	Dec 21	Sep 21
Revenue	INR6.55B	INR8.54B	INR8.62B
EBITDA	INR-2.02B	INR1.14B	INR973.90M
Net Income	INR-2.58B	INR-67.80M	INR335.30M
Total Assets	INR82.43B	INR	INR80.09B
Total Cash	INR4.06B	INR	INR2.50B
Total Debt	INR	INR	INR27.60B

WOCKPHARMA Stock Price History

Wockhardt Annual Stock Price History

Year	Open	Close	Change
2021	INR401.60	INR214.00	-46.71%
2021	INR544.50	INR401.60	-26.24%
2020	INR240.00	INR544.50	126.87%

Wockhardt Daily Stock Price History

Date	Open	High	Low	Close	Change	Volume
Jun 23, 2022	INR216.80	INR224.00	INR216.15	INR221.50	-8.70%	271.17K
Jun 10, 2022	INR243.30	INR247.95	INR241.85	INR242.60	-5.35%	347.63K
Jun 7, 2022	INR262.00	INR262.00	INR252.95	INR256.30	11.90%	383.00K

View More on "Price History" Section

(NSE:WOCKPHARMA) Stock Price FAQs

What is today's stock price of Wockhardt (NSE:WOCKPHARMA)?

The current stock price of Wockhardt (NSE:WOCKPHARMA) is INR214.00.
Today WOCKPHARMA stock price opened at INR214.00 after previous close of INR212.65.
During the day, Wockhardt stock quote has varied from a low of INR213.00 to a high of INR215.65.

What is Wockhardt's 52-week change?

WOCKPHARMA 52-week high stock quote is INR592.00, which is 176.60% above the current share price.
The Wockhardt (NSE:WOCKPHARMA) 52-week low stock price is INR210.05, which is 1.80% below the current share price.
Wockhardt share price volatility (52-week beta) is 1.50.

Wockhardt (NSE:WOCKPHARMA) FAQ

How Much is Wockhardt Worth?

Wockhardt's worth today based on market capitalisation is INR30.83B

How much dividend does Wockhardt Pay?

The current annualized dividend payout for WOCKPHARMA stock is INR0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Wockhardt's "Dividend" Section

What is Wockhardt’s Price to Earning (PE) ratio?

WOCKPHARMA stock also has a Price to Sales (P/S) ratio of 0.95.

What is the Wockhardt's ticker?

Wockhardt trades on the NSE stock market in India under the ticker symbol "WOCKPHARMA". Wockhardt’s stock symbol can also be displayed as "NSE:WOCKPHARMA".

Who are the owners of Wockhardt?

Wockhardt (NSE:WOCKPHARMA) is owned by 1.96% institutional shareholders and by 69.48% insiders. The rest is owned by the public.
Explore More Details on Wockhardt's “Ownership” Section

Who are the key executives of Wockhardt (WOCKPHARMA)?

Wockhardt's key executive team includes the following managers:

Dr. Habil Fakhruddin Khorakiwala, Founder & Exec. Chairman (1941)
Dr. Murtaza Habil Khorakiwala, MD & Exec. Director (1973)
Dr. Huzaifa Habil Khorakiwala, Exec. Director (1971)
Ms. Pradnya Deshmukh, Pres and Global Head of Quality & Compliance (NA)
Mr. Deepak Madnani, Chief Financial Officer (NA)
Mr. Prem Singh, Pres of Global HR (NA)
Mr. Anil V. Kamath AMRSH (Lon.), BCom (Hons), MBIM (Lon.), MIMA, Sr. VP of Bus. Devel. (1951)
Mr. Georg Cubuk, Managing Director of Esparma - Germany (NA)
Mr. Sunil Kumar, Pres of Americas, Emerging Market & Japan (1954)
Mr. Zoher T. Sihorwala, Head of Global Regulatory Affairs (1970)

What is Wockhardt’s Sector & Industry Classification?

Wockhardt (NSE:WOCKPHARMA) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.

How many employees work for Wockhardt?

Currently the number of employees working for Wockhardt is 5,000.

Where are Wockhardt's Headquarters?

Wockhardt (NSE:WOCKPHARMA) is headquartered in India.

What are Wockhardt's Address and Phone Number?

Wockhardt’s mailing address is Wockhardt Towers, Mumbai, India, 400051.
The company’s phone number is 91 22 2653 4444.

What is the official website for Wockhardt?

Wockhardt’s official website is http://www.wockhardt.com

Wockhardt Stock (NSE:WOCKPHARMA)